UnitedHealth Group Incorporated (NYSE:UNH) Holdings Raised by Provident Wealth Management LLC

Provident Wealth Management LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 463 shares of the healthcare conglomerate’s stock after acquiring an additional 60 shares during the quarter. Provident Wealth Management LLC’s holdings in UnitedHealth Group were worth $271,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Harbor Investment Advisory LLC grew its position in UnitedHealth Group by 3.2% during the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after purchasing an additional 1,129 shares in the last quarter. Austin Private Wealth LLC raised its stake in shares of UnitedHealth Group by 9.8% during the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after purchasing an additional 111 shares in the last quarter. Capital Insight Partners LLC grew its stake in shares of UnitedHealth Group by 3.8% in the 1st quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after buying an additional 332 shares in the last quarter. Collective Family Office LLC increased its stake in shares of UnitedHealth Group by 4.3% during the 1st quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock worth $780,000 after purchasing an additional 65 shares during the last quarter. Finally, Global Assets Advisory LLC bought a new position in UnitedHealth Group during the first quarter valued at about $282,469,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 2.7 %

NYSE:UNH opened at $571.30 on Thursday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The stock has a market capitalization of $527.55 billion, a PE ratio of 37.88, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. The business’s 50-day simple moving average is $584.21 and its 200-day simple moving average is $532.84. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $608.63.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the prior year, the business earned $6.56 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.47%. UnitedHealth Group’s dividend payout ratio is 55.70%.

Analysts Set New Price Targets

UNH has been the subject of a number of recent analyst reports. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Wednesday. Bank of America decreased their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their target price for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Wells Fargo & Company upped their price target on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Finally, Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday. One research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $615.16.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.